Alterations in neuroendocrine control of growth hormone secretion in the uremic rat. Chronic renal insufficiency (CR1) is associated with growth failure in children and laboratory rats and is considered to be due, in part, to co-existent malnutrition. Alterations in hypothalamic control of growth hormone (GH) secretion have been suggested in uremic patients. We sought to determine whether factors unique to CR! play a role in this disturbance of GH regulation. Using in situ hybridization histochemistry, we compared messenger RNA (mRNA) levels for the hypothalamic neurohormones GH-releasing hormone (OHRH) and somatostatin (SRIH) in three groups: rats with CR1 induced by 5/6 nephrectomy (NPX, N = 4); sham-operated, ad libitum fed rats (SAL, N = 5); and sham-operated, pair-fed rats (SPF, N = 5). We also measured plasma OH at 10 minute intervals for a six hour period via intra-atrial cannulae. The NPX group had significantly lower hypothalamic GHRH mRNA concentrations than both other groups; in addition, these levels were significantly lower in the SPF than in the SAL group. Concentrations of hypothalamic SRIH mRNA did not differ significantly among the three experimental groups. Six-hour mean plasma OH concentrations were significantly lower in the SPF (18.3 1.8 sg/liter) than in either the SAL (27.0 3.3 sg/1iter) or the NPX groups (36.8 7.2 sg/liter); the difference in the mean plasma OH levels in the NPX vs. the SAL group did not attain statistical significance. This study provides evidence for an effect of CR1 on the neuroendocrine control of OH secretion not related to caloric intake. We hypothesize that a complex interplay of multiple factors leads to altered plasma GH levels in CR1 and ultimately to growth failure. These factors include decreased hypothalamic GHRH gene transcription and decreased metabolic clearance of OH. We speculate that increased circulating SRIH levels of non-hypothalamic origin and altered negative feedback on GH secretion of both OH and insulin-like growth factor I may also play a role in this dysregulation of plasma GH levels in uremia.
appears to be vital in determining growth in the infant with CR1, dietary manipulation beyond the first year of life has had little effect on linear growth. Nevertheless, malnutrition remains an inevitable component of CR1 [1] .
One issue of contention still unresolved is the relative importance and potential interaction of malnutrition and the uremic state itself in contributing to the alterations within the GH axis. In rats, food deprivation has profound effects on the regulation of GH secretion at both the hypothalamic and pituitary levels [2] [3] [4] [5] [6] [7] [8] [9] [10] . CR1 may also lead to abnormalities in the GH axis secondary to alterations in metabolic clearance [11] [12] [13] [14] [15] and distribution volume [12] of the hormone. Interruption of the normal negative feedback on GH secretion because of decreased end-organ responsiveness to both GH and insulin-like growth factor I (IGF-I) has been postulated in uremia [16] [17] [18] [19] [20] . In humans with CR1, elevated baseline GH levels [21] [22] [23] [24] and abnormal (both elevated and depressed) GH secretory responses to various stimuli [25] , such as hyper-and hypoglycemia, arginine, GH-releasing hormone (GHRH) and L-dopa, have been observed. However, isolated somatotropes from rats with CR1 retain normal responsiveness to GHRH in vitro [26, 27] . Thus it appears that the hypothalamus, rather than the pituitary gland, is a major site of dysregulation of GH secretion in the uremic state. However, no investigations at the molecular level into the hypothalamic control of circulating OH have been reported in the rat to date.
We hypothesized that unique effects of CR1 on the GH axis exist independently of those of malnutrition. We employed in situ hybridization histochemistry to study the effects in rats of these two physiologic stressors on the concentrations of messenger RNA (mRNA) for GHRH and somatostatin (SRIH), the two hypothalamic hormones which control pituitary GH synthesis and secretion. In addition, we evaluated the effect of food deprivation and CR1 on plasma concentration of OH, using repeated blood sampling via intra-atrial cannulae [28] . To undertake this study, it was decided to use the well-studied paradigm [8, 29] of inducing CR1 in rats via 5/6 nephrectomy [30] and then comparing these uremic animals with two shamoperated control groups: rats fed ad libitum and those matched for protein and caloric intake.
Methods

Animals
Male Sprague-Dawley rats at 32 days of age and with a mean weight of 91. 8 2.0 g were obtained from Charles River
Laboratories (Wilmington, Massachusetts, USA). They were maintained in individual cages at ambient room temperature on 12-hour light-dark cycles. Tap water was available ad libitum.
Experimental design The experimental protocol was approved by the Institutional Animal Care and Use Committee of the Virginia Commonwealth University.
At 46 days of age and at a mean body weight of 192.3 4.8 g, rats underwent either 5/6 nephrectomy (NPX, N = 5) or sham surgery (N = 10) on day 0 of the study. Surgeries were performed in two stages [30] , using pentobarbital (1.25 mgIlOO g body wt, intraperitoneally) and ketamine (4 mg/100 g body wt, intramuscularly) anesthesia. On day 0, the left kidney was exposed and decapsulated in all rats; the upper and lower thirds of the organ were excised in the NPX group only. On day 7, the right kidney was exposed and decapsulated in all rats. In the NPX group only, the renal pedicle was ligated, and the entire kidney was removed.
For each of the five NPX animals, one of the sham-operated rats was chosen to be its pair-fed (SPF) control; the other five sham-operated rats were fed ad libitum (SAL). All animals received the same diet: standard powdered rat chow (AIN-76 Semipurified Diet, United States Biochemical, Cleveland, Ohio, USA) modified to contain a total of 35.3% casein; protein supplementation was provided to exacerbate the uremic state of the NPX animals and to ensure a normal protein intake in the SPF animals.
Intra-atrial cannulae were placed under ether anesthesia in all rats on day 17, and repetitive plasma sampling for GH using 0.2 ml aliquots (with replacement of the red blood cells after resuspension in normal saline) was undertaken at 10 minute intervals for a period of six hours (from 1030 to 1630 hr) on day 21 [28] . One of the NPX animals died shortly after this procedure and was excluded from the study (N = 4).
All animals were sacrificed by decapitation on day 22. The brains were removed immediately, frozen on dry ice and then stored in aluminum foil and plastic wrap at -80°C until further use. For histological sectioning, the brains were allowed to equilibrate in a cryostat at -16°C. Coronal sections were made at 16 tm and then thaw-mounted on gelatin-coated slides. In situ hybridization histochemistry The following DNA oligoprobes were constructed: a 45-base construct complementary to nucleotides 31-75 of rat preproGHRH mRNA [32] and a 30mer complementary to nudeotides 310-339 of rat preproSRlH mRNA [33] . Oligoprobes were separately 3'-end-labeled [34] to final specific activities of approximately 1 X i09 dpmig.
For each probe, all brain sections (approximately 20 per animal) were processed in a single batch to prevent interassay variability. The methodology for the in situ hybridization has been described elsewhere [35] . The amount of radiolabel added to each slide of four tissue sections was approximately 1 x 106 dpm for GHRH and 3 x 106 dpm for SRIH. The final washes were in 0.5x SSC for one hour at 45°C for GHRH and at 40°C for SRIH. The slides were then exposed to X-ray films, and the latter were developed after 21 days for GHRH and after three days for SRIH.
Densitometric analysis was performed at the Biomedical Image Processing Center of the University of Virginia. The system used consists of a Leitz Orthoplan microscope, a Dage Model 68 Newvicon video camera with external gain and black level control, and a Gould 1P8500 image processing system which are driven by customized image analysis software [36] . All densitometric analyses were performed in a blinded manner by one observer (D.L.M.). Results of densitometry are expressed as the absolute area of signal (in m2), the optical density of the image compared to background (in relative OD units), and the product of these two [referred to here as the OD index, expressed as (pm2 x OD units)].
Immunoassay GH was measured using a radioimmunoassay described previously [37] . The lower limit of detection of this assay was 4.0 .tgIliter. The intra-assay coefficient of variation was 10.5%.
The GH results from one SPF animal were uninterpretable because of technical error.
Data analysis
Results are reported as mean SEM. The normality of all data sets was assessed by the application of the Wilk-Shapiro statistic; logarithmic transformation was undertaken prior to analysis for all data sets not normally distributed. A priori comparisons of data between the SAL rats and either the SPF or the NPX rats were made using the two-tailed, unpaired Student's t-test. Comparisons of results between the SPF and the NPX rats were made with the two-tailed, paired Student's 1-test. A value of P < 0.05 was accepted as statistically significant. Table 1 shows the results of treatment on weight gain, food consumption and food efficiency (defined as g of body weight gained per g of food consumed) in the three experimental groups from day 8 to day 22. Both weight gain and food efficiency were greatest in the SAL group, intermediate in the SPF group and lowest in the NPX group, with significant differences noted among all three groups. In addition, food consumption was significantly greater in the SAL group than in either the SPF or the NPX group.
Results
Localization of quantifiable mRNA for both GHRH and SRIH was observed in the appropriate hypothalamic nuclei of all animals ( Fig. 1 ). Because the reticular pattern of signal for GHRH in the ventromedial nuclei precluded accurate densitometric analysis, only the arcuate nuclei were evaluated for GHRH mRNA content. Since we had previously observed that the rostral portion of the periventricular nucleus corresponding to plates 24 and 25 of the reference rat brain atlas [31] has the highest content of SRIH mRNA (unpublished results), the data from this segment were also analyzed separately.
In Table 2 are shown the results of densitometric analysis of hypothalamic GHRH gene transcript levels. The mean area of the GHRH mRNA signal was significantly decreased in the NPX versus the SAL group (P = 0.01), in the NPX versus the SPF group (P = 0.0002), and in the SPF versus the SAL group (P = 0.04). The mean optical density was significantly lower in the NPX versus the SAL group (P = 0.006). Finally, the mean OD index of the GHRH mRNA signal was significantly decreased in the NPX versus the SAL group (P = 0.005), in the NPX versus the SPF group (P = 0.04), and in the SPF versus the SAL group (P < 0.05). Table 3 lists the results of quantitation of SRIH mRNA levels. Although the mean SRIH mRNA abundance by all measures was highest in the SAL group, intermediate in the NPX group and lowest in the SPF group, these results did not attain statistical significance in the number of rats studied. The only difference noted among the three groups was a significantly larger mean area of SRIH mRNA signal in the NPX versus the SPF group (P = 0.03) in the subsegment of the periventricular nuclei corresponding to reference plates 24 and 25.
In Table 4 are shown the results of the six-hour mean plasma GH concentrations for the three groups of experimental animals. Mean GH levels were significantly higher in the SAL versus the SPF group (P < 0.05), and they were also greater in the NPX versus the SPF group (P = 0.03). Although the mean GH concentrations were higher in the NPX versus the SAL group, this difference did not attain statistical significance. Also shown are the recently reported [15] GH plasma elimination half-lives for these animals, as determined by deconvolution analysis [11] of plasma GH concentration-versus-time series.
The half-life is significantly greater in the NPX versus both the SAL (P = 0.002) and the SPF (P = 0.02) groups; it is also significantly greater in the SPF versus the SAL group (P 0.01).
Discussion
In this study, we hypothesized that both malnutrition and CR1-specific factors can alter the physiology of GH secretion in the uremic rat. Using in Situ hybridization histochemistry, we have demonstrated significant reductions in gene expression of GHRH, one of the major hypothalamic neuroregulators of GH release, in food-deprived and uremic rats. Associated with these changes was a marked decrease in six-hour mean plasma GH concentrations in the malnourished (pair-fed) rats compared to both the ad libitum fed and the uremic rats. Given the alterations in hypothalamic GHRH mRNA content-which are significantly more pronounced in CR1 than in simple food deprivation-and the divergent plasma GH levels among the three groups, we contend that factors in uremia other than decreased caloric intake are involved in the etiology of these observed changes.
The experimental model used here, 5/6 nephrectomy, produces a state of mild to moderate renal failure with elevated plasma urea nitrogen and creatinine levels [8, 23, 26, 27, 29, 30] .
Nephrectomized animals also exhibit markedly decreased caloric intake and food efficiency, which result in poor weight gain and decreased linear growth [8, 23, 26, 27] . Sham-operated, pair-fed animals generally demonstrate weight gain, linear growth and food efficiency intermediate between nephrectomized and ad libitum fed controls [8, 23] . The results presented in Table 1 are therefore compatible with previous findings.
Food deprivation has profound effects on the GH axis of the rat. Our finding of significantly decreased plasma GH concentrations in the SPF versus the SAL rats confirms previous observations in the food-deprived rat [2, [4] [5] [6] [7] . Moreover, the deconvolution-derived GH elimination half-life is significantly longer in the SPF versus the SAL rats [15] ; other researchers have also documented that fasting in rats is associated with a decrease in both the metabolic clearance rate and the apparent distribution volume of GH [38] . It is therefore likely that the lower plasma GH levels observed in the food-deprived (SPF) rats specifically reflect decreased pituitary GH secretion. The cause of this diminution in GH production is not known with certainty. Using an early bioassay, Meites and Fiel [3] demonstrated that the hypothalami of starved rats contain less GHRHlike activity than controls fed ad libitum. This is corroborated by our observation that the SPF animals have significantly lower hypothalamic GHRH mRNA content than the SAL group. Similar findings of decreased GHRH mRNA levels-but with normal GHRH peptide content-in the hypothalami of starved rats have also been observed by Bruno et al [9] ; this appears to a specific effect of protein deprivation [10] . It should be mentioned that these findings in rats are in sharp contradistinction to those in humans, in whom fasting is associated with large increases in GH secretion [39] .
Increased SRIH tone also appears to play a role in the decreased plasma GH levels of starvation. Endogenous and exogenous SRIH have inhibitory effects on both hypothalamic GHRH release and pituitary GH secretion [40] . Indeed, functional SRIH receptors have been identified on GHRH-secreting neurons in the hypothalamic arcuate nucleus [41] . Tannenbaum and colleagues [2] showed that passive immunization with antiserum to SRIH restores normal pulsatile GH secretion in malnourished rats. While it is agreed that fasted rats have increased circulating plasma concentrations of SRIH similar to normal peak concentrations in hypothalamic portal blood [6] , the source of this SRIH is disputed. Mounier and coworkers [7] demonstrated that mean GH levels do not decrease further with starvation in rats which have undergone hypothalamic-pituitary disconnection, indicating that the increased SRIH of starvation Fig. 1 . Autoradiographs on X-ray film from in situ hybridization for GJJRH and SRI!! mRNA in the hypothalamus of a control rat. There is dense localization of OHRH mRNA in the arcuate nuclei (A). Note also the fainter, reticular pattern of signal in the ventromedial nuclei. B. Demonstrates the dense localization of SRIH iriRNA in the periventricular nuclei of the hypothalamus; there is also diffuse signal throughout the cerebral cortex consistent with the role of SRII-l as a prevalent neurotransmitter. is of central origin. Other investigators, however, have observed increased levels of SRIH peptide in the pancreas and gut-but not in the hypothalamus-of food-deprived rats [5] . indeed, there is a significant increase of SRIH mRNA content in rat gastric antrum within 12 hours of the onset of fasting [42] .
Bruno and coworkers [91 likewise found unchanged SRIH mRNA and peptide concentrations in the hypothalami of starved rats versus fed controls. In our study, the hypothalamic content of SRIH inRNA is statistically indistinguishable in the SAL and the SPF animals. We are therefore unable to provide Elimination half-lives were determined by deconvolution analysis and previously reported in reference 15. Within a row, differences in data not sharing identical superscripts are statistically significant (P < 0.05). See Table 1 for abbreviations. further evidence for the origin of the increased SR1H tone in starvation.
CR1 also exerts a number of effects on the OH axis [14] . Studies in humans have shown that random and serial OH concentrations are generally increased in CR1 [21, 22, 241. Likewise, one previous study has demonstrated higher random OH concentrations in uremic rats compared to both ad libiturn and pair-fed controls [23] . However, while Lacour and colleagues did not observe any differences in random serum OH concentrations between similar groups, they did demonstrate significantly higher pituitary (3M content in uremic rats than in control rats fed ad libitum [29] . This latter phenomenon is consistent with the finding of increased SRIH tone in CR! [43] .
This study represents the only investigation to date using repeated blood sampling for OH in uremic rats. While our data suggest that mean plasma OH concentrations may be elevated in the uremic (NPX) versus the SAL group, this difference did not attain statistical significance in our limited number of animals. Nonetheless, mean plasma OH levels are significantly higher in the NPX than in the SPF group; this suggests that there may be two opposing influences on OH concentrations in rats with CR1: starvation, which is inhibitory to OH production, and some factor(s) unique to uremia which is causing an apparent elevation in plasma OH concentrations. Additionally, it is unknown whether some partially degraded, bioinactive forms of OH could interfere with the R!A and result in spuriously high immunoactive OH levels [14, 38] .
Either a decrease in metabolic clearance or an increase in pituitary GH secretion, or both, could lead to increased circulating OH in rats with CR1. Plasma GH elimination half-life is significantly greater in the NPX versus either the SPF or the SAL group [15] ; similar findings have also been demonstrated in humans [12, 14, 24] . Since up to 70% of circulating OH may be degraded in the rat kidney [13] , this increased elimination half-life may reflect a reduction of glomerular clearance of OH in CR1. GH is also eliminated from the plasma through its binding to GH receptors on target tissues with subsequent hormone-receptor complex internalization and lysosomal degradation [44] . A decrease in the number of hepatic OH-binding sites, such as is observed in uremic rats [16] , could therefore lead to reduced clearance of GH. A decrease in GH-binding protein, such as has been documented in uremic children [17] , or an alteration in its binding equilibrium with GH could also potentially affect hormone clearance [14] . Finally, the volume of distribution of growth hormone is significantly increased in human with CR1 [12] ; any estimate of endogenous GH production or clearance must necessarily take this fact into consideration.
Direct measurements of OH production rates were not performed in this study; these await the application of newer mathematical techniques, such as deconvolution modeling [11] , to a larger number of plasma OH concentration-versus-time series from uremic humans and rats. Nonetheless, the finding of significantly lower hypothalamic levels of GHRH mRNA in the NPX versus the SAL rats offers indirect evidence that GH production may be severely diminished in CR1. Furthermore, because these values are even lower in the NPX versus the SPF rats, this decrease in hypothalamic GHRH mRNA content associated with CR1 cannot be ascribed to caloric deprivation alone. Since the hypothalamic content of SRIH mRNA was not significantly different between the NPX and the SPF group, we are unable to explain the higher GH concentrations in the NPX group on the basis of altered hypothalamic SRIH input. Nevertheless, plasma SRIH peptide concentrations are increased in adults with CR1 [43] . The reason for this is uncertain, but it does not appear to be a result of impaired metabolic clearance of SRIH [43] . It is also unknown whether plasma SRIH levels are higher in uremic rats versus pair-fed controls, that is, whether malnutrition is the sole reason for the elevated SRIH. Future studies will need to elucidate the relative contributory roles of decreased GH clearance and neuroendocrine dysregulation of OH secretion to the observed alterations of plasma GH levels.
At present, it is not known which factor(s) peculiar to uremia might explain the non-caloric intake-related alterations in hypothalamic control of GH secretion. In healthy humans and rats, both OH and IGF-I exert negative feedback inhibition on OH production; this is mediated at least in part through SRIH [40] . A state of primary resistance to GH is postulated to occur in CR1, since uremic rats have fewer hepatic OH-binding sites than controls [16] , and children with CR1 have decreased plasma concentrations of OH-binding protein, an indirect measure of GH receptor number [17] . However, the significance of these alterations on hormone end-organ action have not been completely elucidated. Notwithstanding any resistance to OH, the product of its action on target tissues, IGF-I, is found in normal concentrations by immunoassay in the plasma of children [18] and rats [8] with CR!. However, the bioactivity of IGF-I is reduced, probably because of the accumulation in Fig. 2 . Hypothetical model of the effects in the rat of caloric deprivation and CR1 on GH secretion and elimination as manifested by alterations in peripheral OH concentrations. In malnutrition (left), GH production is decreased secondary to diminished hypothalamic GHRH synthesis and to increased SRIH tone, probably of non-hypothalamic origin. Despite a small increase in plasma elimination half-life, peripheral levels of OH are decreased in malnutrition. In CR1 (right), hypothalamic GHRH levels are lower still, leading to decreased OH production; in addition, plasma OH half-life is markedly prolonged in CR!. The effects of co-existent malnutrition and CR1-specific factors lead to an overall increase in plasma OH levels in the uremic rat.
uremia of IGF-binding proteins [18, 20] , which act to maintain free IOF-I at very reduced concentrations. In addition, other researchers have identified a low molecular weight (<1 kD), non-protein, dialyzable inhibitor of IGF-I-induced sulfate and uridine uptake into cartilage [19] . If this end-organ resistance to GH and/or IGF-I extended to the hypothalamic-pituitary-OH axis, GHRH gene transcription might be expected to increase to provide a compensatory rise in OH secretion. Since this was not observed in our experiment, other unidentified factors may be involved which inhibit GHRH gene expression.
In summary, our preliminary study in a limited number of animals has demonstrated that the neuroendocrine regulation of GH secretion is altered at the hypothalamic level in rats with CR1 (Fig. 2) . We observed that uremic rats have decreased hypothalamic concentrations of mRNA for GHRH, even when compared to pair-fed controls. This provides evidence for an effect of uremia on hypothalamic OHRH gene expression that is not related to caloric intake. We were unable to demonstrate alterations in SRIH mRNA content in the hypothalamus caused by either food deprivation or CR1. Despite the decreased OHRH mRNA content and the unchanged SRIH mRNA content in the hypothalamus, plasma GH levels are increased in CR!. We speculate that other factors are involved which may alter GH concentrations in CR1. These could include decreased renal (and perhaps extrarenal) clearance and increased distribution volume of the hormone, increased SRIH tone of nonhypothalamic origin, as well as alterations of GH and IGF-I negative feedback on the neuroendocrine regulation of OH secretion.
